Growth PotentialThe current balance sheet suggests over EUR 200M additional re-leveraging room, indicating potential for further growth through external acquisitions.
Strategic AcquisitionsAscopiave's interest in a portion of Italgas/2i Rete Gas’ remedies, worth a total of around EUR 0.6Bn, shows potential for further strategic acquisitions.
Valuation SupportThe market is not currently pricing in the renewables’ arm and Associates’ portfolio, which offers some further valuation support to the stock.